Gm1 gangliosidosis Clinical Trials
Conditions / Gm1 gangliosidosis
Delta Trials catalogs 13 clinical trials for Gm1 gangliosidosis in its publicly accessible dataset. Within this set, 3 currently recruiting participants and 6 trials have reached completion. This research occurs across 59 participating sites around the world. An additional 4 trials are in other active phases such as not yet recruiting or pending status. Since 2020, 1 trial were withdrawn or terminated prior to completion. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations and statuses evolve over time.
Trial Status
13
Total Trials
3
Recruiting
6
Completed
4
Other Active
1
Terminated since 2020
59
Study Locations
Browse by location (59 total)
- Porto Alegre, Brazil 5 trialsAll trials in Porto Alegre, Brazil
- Porto Alegre, Brazil 5 trialsAll trials in Porto Alegre, Brazil
- London, United Kingdom 5 trialsAll trials in London, United Kingdom
- Minneapolis, United States 5 trialsAll trials in Minneapolis, United States
- Paris, France 4 trialsAll trials in Paris, France
- Paris, France 4 trialsAll trials in Paris, France
- Oakland, United States 4 trialsAll trials in Oakland, United States
- Milan, Italy 3 trialsAll trials in Milan, Italy
- Rochester, United States 3 trialsAll trials in Rochester, United States
- Bern, Switzerland 2 trialsAll trials in Bern, Switzerland
- Ankara, Turkey (türkiye) 2 trialsAll trials in Ankara, Turkey (türkiye)
- Curitiba, Brazil 2 trialsAll trials in Curitiba, Brazil
- Fairfax, United States 2 trialsAll trials in Fairfax, United States
- Montréal, Canada 2 trialsAll trials in Montréal, Canada
- Montréal, Canada 2 trialsAll trials in Montréal, Canada
- Montréal, Canada 2 trialsAll trials in Montréal, Canada
- Barcelona, Spain 2 trialsAll trials in Barcelona, Spain
- Höchheim, Germany 2 trialsAll trials in Höchheim, Germany
- Porto, Portugal 2 trialsAll trials in Porto, Portugal
- Manchester, United Kingdom 2 trialsAll trials in Manchester, United Kingdom